Compassionate Use of Remdesivir for Patients with Severe Covid|19

Compassionate Use of Remdesivir for Patients with Severe Covid-19

In this report, we describe outcomes in a cohort of patients hospitalized for severe Covid-19 who were treated with remdesivir on a compassionate-use basis.

Compassionate Use of Remdesivir for Patients with Severe Covid-19

In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was ...

Compassionate Use of Remdesivir for Patients with Severe Covid-19

We provided remdesivir on a compassionate-use basis to patients hospitalized with. Covid-19, the illness caused by infection with SARS-CoV-2 ...

Compassionate use of remdesivir for treatment of severe ...

A report of 61 nonpregnant patients with moderate to severe COVID-19 who received at least 1 dose of remdesivir indicated clinical improvement in 68% of ...

Compassionate Use of Remdesivir in Children With Severe COVID-19

By day 28 after the initiation of remdesivir dosing, 83% of patients (64 of 77) had recovered: 79% (31 of 39) of those on invasive respiratory ...

Compassionate Use of Remdesivir for Patients with Severe Covid-19

A cohort of patients with severe Covid-19 received treatment with remdesivir under a compassionate-use protocol. Improvement in oxygen-support status was ...

Compassionate Use of Remdesivir in Pregnant Women With Severe ...

Remdesivir is efficacious for severe coronavirus disease 2019 (COVID-19) in adults, but data in pregnant women are limited. We describe outcomes ...

Remdesivir in adults with severe COVID-19 - The Lancet

No specific antiviral drug has been proven effective for treatment of patients with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a ...

EMA recommends expanding remdesivir compassionate use to ...

In addition to patients undergoing invasive mechanical ventilation, the compassionate use recommendations now cover the treatment of ...

Results of Compassionate-Use Remdesivir for Severe COVID-19

Need for oxygen support improved in 68% of the patients. · Of those receiving mechanical ventilation, 57% were extubated. · Three of four people ...

EMA provides recommendations on compassionate use of ...

Remdesivir is an antiviral medicine which is being investigated for the treatment of COVID-19. Remdesivir is a 'viral RNA polymerase inhibitor' ...

expert reaction to a study about compassionate use of remdesivir for ...

expert reaction to a study about compassionate use of remdesivir for patients with severe COVID-19 ... A study, published in The New England ...

Compassionate use of remdesivir for patients with severe COVID-19

This preliminary case series of patients hospitalized with severe Covid-19 who were treated with compassionate-use remdesivir found that 68% ...

Compassionate Use of Remdesivir in Pregnant Women With Severe ...

Access through compassionate use was limited to hospitalized patients with severe COVID-. 19, defined as presence of SARS-CoV-2 infection, ...

Compassionate Use of Remdesivir for Patients with Severe Covid-19

severe side effects, including septic shock and kidney failure. But it's definitely not correct to say this drug worked on 66% percent of the sick patients ...

Compassionate remdesivir treatment of severe Covid-19 pneumonia ...

Our data suggest that remdesivir can benefit patients with SARS-CoV-2 pneumonia hospitalised outside ICU where clinical outcome was better and adverse events ...

Compassionate use of remdesivir in children with COVID-19

Children represent a minority of total COVID-19 cases, but studies have reported severe disease and death in pediatric patients. Remdesivir ...

Compassionate Use of Remdesivir for Patients with Severe Covid-19.

METHODS: We provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness caused by infection with SARS- ...

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Compassionate Use of Remdesivir for Patients with Severe Covid-19 · Improvement in oxygen-support status was observed in 68% of patients, and ...

Remdesivir for COVID-19: match-population analysis with ... - medRxiv

on compassionate use of Remdesivir for patients with severe COVID-19 based on the FDA and Gilead Sciences approval before the restriction ...